PBH vs PEGA
PBH: Prestige Consumer Healthcare is a branded OTC healthcare company that manages a diverse portfolio of essential household and personal care products. PEGA: Pegasystems provides an enterprise AI platform for real-time decisioning and workflow automation that helps organizations modernize processes and transform customer experiences.
Side-by-side fundamentals
| Metric | PBH | PEGA | Edge |
|---|---|---|---|
| Price as of 2026-10-30 close | $49.06 | $33.93 | |
| Market cap | $2.3B | $5.6B | |
| P/E as of 2026-10-30 | 13.74 | 20.94 | PBH lower |
| Net margin | +17.5% | +22.5% | PEGA higher |
| Gross margin | +54.7% | +75.9% | PEGA higher |
| Operating margin | +28.4% | +15.1% | PBH higher |
| ROE | +10.1% | +50.0% | PEGA higher |
| ROA | +5.4% | +24.1% | PEGA higher |
| Debt / equity filed borrowings, leases excl., balance sheet 2026-06-30 | 1.05 | n/a | |
| Revenue growth (YoY) | -4.3% | +16.6% | PEGA higher |
| Revenue CAGR (3y) SEC XBRL | -1.2% | +9.8% | PEGA higher |
| Dividend yield as of 2026-09-02 | n/a | 0.35% | |
| Dividend streak (yrs) SEC XBRL | 0 | 17 | PEGA higher |
| Beta as of 2026-09-02 | 0.38 | 1.22 | |
| 1-year return as of 2026-10-30 close | -18.6% | -46.6% | PBH higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-30.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.